DNMT1 and neoplasm: At the epigenetic level, it has been demonstrated that EGCG inhibits the activity of DNMTs (particularly DNMT1) in several tumor cell lines, including breast, colon, prostate, and esophageal tumor cells, thereby promoting the reactivation of antioxidant enzymes.